|
Doroudchi, Mehrnoosh; Yegorov, Oleg; Baumgartner, Tom et al. (2012) Autologous HIV-1 clade-B Nef peptides elicit increased frequency, breadth and function of CD8+ T-cells compared to consensus peptides. PLoS One 7:e49562
|
|
Ndongala, Michel L; Kamya, Philomena; Boulet, Salix et al. (2010) Changes in function of HIV-specific T-cell responses with increasing time from infection. Viral Immunol 23:159-68
|
|
Ndongala, Michel L; Peretz, Yoav; Boulet, Salix et al. (2009) HIV Gag p24 specific responses secreting IFN-gamma and/or IL-2 in treatment-naive individuals in acute infection early disease (AIED) are associated with low viral load. Clin Immunol 131:277-87
|
|
Salha, M-D; Cheynier, R; Halwani, R et al. (2008) Persistence of restricted CD4 T cell expansions in SIV-infected macaques resistant to SHIV89.6P superinfection. Virology 377:239-47
|
|
Boulet, Salix; Ndongala, Michel L; Peretz, Yoav et al. (2007) A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses. J Immunol Methods 320:18-29
|
|
Bernardin, Flavien; Kong, Denice; Peddada, Lorraine et al. (2005) Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes. J Virol 79:11523-8
|
|
Makedonas, George; Bruneau, Julie; Alary, Michel et al. (2005) Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally. AIDS 19:251-9
|
|
Alter, G; Hatzakis, G; Tsoukas, C M et al. (2003) Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection. J Immunol 171:477-88
|
|
Alter, Galit; Merchant, Alefia; Tsoukas, Christos M et al. (2002) Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infection. J Infect Dis 185:755-65
|
|
Makedonas, George; Bruneau, Julie; Lin, Henry et al. (2002) HIV-specific CD8 T-cell activity in uninfected injection drug users is associated with maintenance of seronegativity. AIDS 16:1595-602
|
